OnKure Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
OnKure Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2025.
  • OnKure Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2025 was 23.1 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 23.1 +36 Jun 30, 2025
Q1 2025 -40.2 -163 -133% Mar 31, 2025
Q4 2024 -7.5 -29.2 -135% Dec 31, 2024
Q3 2024 -3.52 -21.7 -119% Sep 30, 2024
Q2 2024 -12.8 -29.4 -177% Jun 30, 2024
Q1 2024 123 +108 +725% Mar 31, 2024
Q4 2023 21.7 +9.96 +84.9% Dec 31, 2023
Q3 2023 18.2 +11.3 +163% Sep 30, 2023
Q2 2023 16.6 +10.9 +191% Jun 30, 2023
Q1 2023 14.8 +10.5 +241% Mar 31, 2023
Q4 2022 11.7 +6.7 +133% Dec 31, 2022
Q3 2022 6.9 -1.28 -15.6% Sep 30, 2022
Q2 2022 5.7 Jun 30, 2022
Q1 2022 4.35 Mar 31, 2022
Q4 2021 5.04 Dec 31, 2021
Q3 2021 8.19 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.